 |
Viatris
VTRS
|
$ 13.2
|
15.8 B
|
$ 172 M
|
-4.7
|
1.1
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 6.41
|
3.96 B
|
$ -105 M
|
-2.8
|
4.8
|
$ -2.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 4.99
|
1.82 B
|
$ 3.23 B
|
-4.6
|
0.2
|
$ -1.1
|
 |
 |
Cronos Group
CRON
|
$ 2.51
|
1.31 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Perrigo Company plc
PRGO
|
$ 9.43
|
1.31 B
|
$ 579 M
|
-45.6
|
0.3
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 34.02
|
1.25 B
|
$ 17.6 M
|
-75.6
|
5.4
|
$ -0.4
|
 |
 |
Pacira BioSciences
PCRX
|
$ 22.49
|
1.04 B
|
$ -75.6 M
|
-7.6
|
1.5
|
$ -3.0
|
 |
 |
Solid Biosciences
SLDB
|
$ 6.87
|
601 M
|
$ -115 M
|
-3.1
|
31.7
|
$ -2.3
|
 |
 |
Emergent BioSolutions
EBS
|
$ 7.98
|
409 M
|
$ -238 M
|
-1.1
|
0.4
|
$ -7.5
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 2.42
|
319 M
|
$ 2.42 M
|
-35.3
|
0.7
|
$ -0.1
|
 |
 |
Veru
VERU
|
$ 2.29
|
309 M
|
$ -31.2 M
|
-1.6
|
22.9
|
$ -1.4
|
 |
 |
Evolus
EOLS
|
$ 4.54
|
293 M
|
$ -48.4 M
|
-4.2
|
1.1
|
$ -1.1
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 5.8
|
229 M
|
$ -165 M
|
-3.1
|
-216.0
|
$ -1.9
|
 |
 |
Assertio Holdings
ASRT
|
$ 14.91
|
95.5 M
|
$ -3.27 M
|
-63.6
|
0.7
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.9
|
44.9 M
|
$ -72.9 M
|
-1.8
|
16.8
|
$ -0.5
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 3.05
|
42.9 M
|
$ 1.01 M
|
-14.5
|
1.1
|
$ -0.2
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.31
|
24.1 M
|
$ -3.18 M
|
-46.2
|
9.0
|
$ -0.0
|
 |
 |
Rockwell Medical
RMTI
|
$ 1.03
|
24 M
|
$ 1.12 M
|
-25.5
|
0.3
|
$ -0.0
|
 |
 |
China Pharma Holdings
CPHI
|
$ 0.63
|
11 M
|
$ -1.98 M
|
-0.5
|
2.7
|
$ -1.2
|
 |
 |
cbdMD
YCBD
|
$ 0.76
|
3.28 M
|
$ -1.22 M
|
-0.2
|
0.2
|
$ -3.9
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 2.42
|
3 M
|
$ -5.22 M
|
-1.2
|
0.2
|
$ -2.2
|
 |